Better Therapeutics, Inc. (BTTX) Interest Expense USD 2021 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Better Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2021 to 2023.
  • Better Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2023 was $518 K, a 27.6% increase year-over-year.
  • Better Therapeutics, Inc. Interest Expense for the twelve months ending September 30, 2023 was $1.95 M.
  • Better Therapeutics, Inc. annual Interest Expense for 2022 was $1.49 M, a 706% increase from 2021.
  • Better Therapeutics, Inc. annual Interest Expense for 2021 was $185 K, a 85% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $1.95 M $518 K +$112 K +27.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.84 M $563 K +$234 K +71.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.61 M $431 K +$114 K +36% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.49 M $439 K Oct 1, 2022 Dec 31, 2022 10-K 2023-03-30
Q3 2022 $406 K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $329 K +$328 K +32800% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $317 K +$315 K +15750% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q2 2021 $1 K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $2 K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.